RxSight (RXST) Net Cash Flow (2020 - 2026)

RxSight (RXST) has 7 years of Net Cash Flow data on file, last reported at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 121.08% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$10.4 million (down 126.31% YoY), and the FY2025 full-year result was $3.2 million, down 54.11% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$2.4 million, up from -$9.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $29.6 million in Q2 2022 and bottomed at -$29.9 million in Q1 2022.
• The 5-year median for Net Cash Flow is -$824000.0 (2023), against an average of -$402470.6.
• The widest annual swing landed in 2024, when Net Cash Flow jumped 2886.04%; it then slumped 26952.78% in 2025.
• A 5-year view of Net Cash Flow shows it stood at $2.9 million in 2022, then slumped by 106.05% to -$173000.0 in 2023, then soared by 120.81% to $36000.0 in 2024, then plunged by 26952.78% to -$9.7 million in 2025, then surged by 75.39% to -$2.4 million in 2026.
• The last three Net Cash Flow figures came in at -$2.4 million (Q1 2026), -$9.7 million (Q4 2025), and -$10.7 million (Q3 2025), per Business Quant data.

Peer Comparison